Related Experiment Video

Updated: Aug 7, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism

John J Engelhardt1, Timothy J Sullivan, James P Allison

  • 1Division of Immunology, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|July 5, 2006
PubMed

Insights

Overexpressing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) in mice inhibits T cell activation. This immune regulation involves B7 and CD28 interactions, impacting T cell responses.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a key negative regulator of T cell activation.
  • Understanding CTLA-4's inhibitory mechanisms is crucial for immune system research.

Purpose of the Study:

  • To investigate the inhibitory role of CTLA-4 by creating transgenic mice with constitutive T cell surface expression.
  • To elucidate the molecular mechanisms underlying CTLA-4-mediated T cell inhibition.

Main Methods:

  • Construction of CTLA-4 transgenic mice with constitutive expression on CD4 and CD8 T cells.
  • Assessment of in vivo and in vitro T cell responses.
  • Analysis of the dependence on B7 and CD28 interactions.

Main Results:

  • Constitutive CTLA-4 overexpression significantly inhibits T cell activation in both in vivo and in vitro settings.
  • The inhibitory effect is dependent on B7 and CD28, suggesting competition for binding or interference with signaling pathways.
  • Transgene expression reduced the number of CD25+Foxp3+ T cells but did not impair their suppressive function.

Conclusions:

  • CTLA-4 acts as a potent negative regulator of T cell activation.
  • CTLA-4's inhibitory action is mediated through multiple mechanisms, including competition with CD28 for B7 binding and interference with CD28 signaling.
  • While CTLA-4 affects regulatory T cell populations, its core suppressive function remains intact.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.